Trajectory tanulmány: A kardiometabolikus egészség előrejelzése serdülők és fiatal felnőtteknél, gyermekkori fitnesz, alvás és étrend alapján (Trajectory)

Adolescents (13 to 17 years) and young adults (18 to 21 years) who previously participated in the Arkansas Active Kids study (clinicaltrials.gov #NCT03221673; IRB #206217) and the MI Energy study (clinicaltrials.gov #NCT04427462; IRB #260376).

Inclusion Criteria:

• Ages 13 to 21 years.
• Boys or girls.
• All ethnicities.
• All BMIs.
• Previous participation in the Arkansas Active Kids study and the MI Energy study.
• Participants who previously agreed to be contacted for future research at ACNC.
• Participants who agree to the use of their previously collected information and samples from the AAK or MI Energy studies for the follow-up study.

Exclusion Criteria:

• Asthma that requires daily use of inhalers to keep symptoms under control.
• Asthma that requires use of rescue inhalers (e.g., albuterol) >2 days per week.
• Exercise-induced asthma.
• Autism spectrum disorder (e.g., Autistic disorder, Rett disorder, Asperger disorder, childhood disintegrative disorder, pervasive developmental disorder not otherwise specified (PDD-NOS).
• Neurological disorders (e.g. epilepsy or seizures).
• Cancer.
• Hormonal disease (e.g., hypothyroidism and growth hormone deficiency).
• Autoimmune diseases (e.g., lupus, thyroiditis, juvenile idiopathic arthritis).
• Bleeding disorders (e.g., hemophilia).
• Chronic infections (e.g., HIV, hepatitis B, hepatitis C).
• Other pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest.
• Pregnancy (verbal assessment).